Improving communication about treatment options for asymptomatic ovarian cancer patients with rising cancer antigen 125 (CA-125): A randomised controlled trial of a Decision Aid
Not Applicable
- Conditions
- Communication about treatment options and decision making for women with asymptomatic ovarian cancer and rising CA-125 levels.Cancer - Ovarian and primary peritoneal
- Registration Number
- ACTRN12609001035213
- Lead Sponsor
- Centre for Medical Psychology and Evidence-based Decision-making
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- Female
- Target Recruitment
- 178
Inclusion Criteria
Women with a diagnosis of epithelial ovarian cancer, who have undergone tumour debulking / cyto-reductive surgery, have completed first-line chemotherapy, and are currently asymptomatic during follow-up with rising CA-125 levels.
Exclusion Criteria
Women who do not understand sufficient English to read the booklet and complete the questionnaires, have a concurrent psychiatric disorder or are cognitively impaired are not eligible for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure for this study will be satisfaction and difficulties with decision-making, assessed using the validated Decisional Conflict Scale (DCS).[This will be assessed in a questionnaire that the women complete after they have both read the booklet and made a treatment decision. There is no specific time frame in which this must occur.]
- Secondary Outcome Measures
Name Time Method